Similarly, TIMP-3 overexpression in mouse macrophages reduced adipose inflammation, insulin resistance, nonalcoholic fatty liver disease, and atherosclerotic plaques in an atherosclerosis mouse model [11,12]. Here, TIMP3 is linked to metabolic dysfunction-associated steatotic liver disease.